These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 87927)

  • 41. Drug treatment of onchocerciasis.
    Orme M; Awadzi K; Edwards G; Breckenridge AM
    Q J Med; 1988 Mar; 66(251):195-201. PubMed ID: 3059388
    [No Abstract]   [Full Text] [Related]  

  • 42. [Visual disorders as key symptoms of ocular migraine].
    Pittke EC
    Klin Monbl Augenheilkd; 1986 Oct; 189(4):317-22. PubMed ID: 3807224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comments upon onchocerciasis (author's transl)].
    Vedy J; Graveline J; Cahuzac G
    Med Trop (Mars); 1981; 41(5):503-4. PubMed ID: 7321841
    [No Abstract]   [Full Text] [Related]  

  • 44. Visual field defects in onchocerciasis.
    Thylefors B; Tønjum AM
    Br J Ophthalmol; 1978 Jul; 62(7):462-7. PubMed ID: 678499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Etretinate and visual function: a 1-year follow-up study.
    Pitts JF; Mackie RM; Dutton GN; McClure EA; Allan D
    Br J Dermatol; 1991 Jul; 125(1):53-5. PubMed ID: 1873203
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Digoxin visual toxicity with therapeutic blood levels of digoxin.
    Wolin MJ
    Am J Ophthalmol; 1998 Mar; 125(3):406-7. PubMed ID: 9512168
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adverse ocular effects of flecainide.
    Ikäheimo K; Kettunen R; Mäntyjärvi M
    Acta Ophthalmol Scand; 2001 Apr; 79(2):175-6. PubMed ID: 11284757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hydroxychloroquine: A Brief Review on Screening, Toxicity, and Progression.
    Modi YS; Singh RP; Fine HF
    Ophthalmic Surg Lasers Imaging Retina; 2016 Mar; 47(3):207-17. PubMed ID: 26985794
    [No Abstract]   [Full Text] [Related]  

  • 49. Chemotherapy of onchocerciasis: a controlled clinical trial of topical diethylcarbamazine (DEC) in Guatemala.
    Taylor HR; Langham ME; de Stahl EM; Figueroa LN; Beltranena F
    Tropenmed Parasitol; 1980 Sep; 31(3):357-64. PubMed ID: 7003855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.
    Albiez EJ; Newland HS; White AT; Kaiser A; Greene BM; Taylor HR; Büttner DW
    Trop Med Parasitol; 1988 Mar; 39(1):19-24. PubMed ID: 3291074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Clonidine side effect in the human eye.
    Turacli ME
    Ann Ophthalmol; 1974 Jul; 6(7):699-709. PubMed ID: 4843885
    [No Abstract]   [Full Text] [Related]  

  • 52. [The therapeutic difficulties of ocular onchocerciasis].
    Toufic N
    Arch Ophtalmol Rev Gen Ophtalmol; 1969 Nov; 29(11):777-84. PubMed ID: 4243964
    [No Abstract]   [Full Text] [Related]  

  • 53. Interleukin-6 and tumor necrosis factor in the pathogenesis of adverse reactions after treatment of lymphatic filariasis and onchocerciasis.
    Turner PF; Rockett KA; Ottesen EA; Francis H; Awadzi K; Clark IA
    J Infect Dis; 1994 May; 169(5):1071-5. PubMed ID: 8169393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Visual function loss from vigabatrin: effect of stopping the drug.
    Johnson MA; Krauss GL; Miller NR; Medura M; Paul SR
    Neurology; 2000 Jul; 55(1):40-5. PubMed ID: 10891902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The chemotherapy of onchocerciasis II. Quantitation of the clinical reaction to microfilaricides.
    Awadzi K
    Ann Trop Med Parasitol; 1980 Apr; 74(2):189-97. PubMed ID: 7002073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Onchocerciasis [proceedings].
    Zuidema PJ
    Dermatologica; 1977; 154(1):54-6. PubMed ID: 844644
    [No Abstract]   [Full Text] [Related]  

  • 57. A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis.
    Diallo S; Aziz MA; Lariviere M; Diallo JS; Diop-Mar I; N'Dir O; Badiane S; Py D; Schulz-Key H; Gaxotte P
    Trans R Soc Trop Med Hyg; 1986; 80(6):927-34. PubMed ID: 3299905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Short review of pathophysiology and therapeutic possibilities in onchocerciasis with reference to a case report].
    Winkler S; Wenisch C; Wiesinger E; Breyer S; Graninger W
    Wien Klin Wochenschr; 1994; 106(11):354-8. PubMed ID: 8053203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of various concentrations of diethylcarbamazine citrate applied as eye drops in ocular onchocerciasis, and the possibilities of improved therapy from continuous non-pulsed delivery.
    Jones BR; Anderson J; Fuglsang H
    Br J Ophthalmol; 1978 Jul; 62(7):428-39. PubMed ID: 678494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Triamcinolone in the prevention of secondary reactions to hetrazan].
    Berhard JA; Figueroa LN; García Manzo GA
    Salud Publica Mex; 1964; 6(5):835-41. PubMed ID: 5889350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.